CUA Educational Content

How have the recent clinical trials in Prostate Cancer informed my practice choices?


Session #2 of the Prostate Cancer and Cardiovascular Disease program series
In partnership with IC-OS and EAU

sponsors


DESCRIPTION:

  • The shifting landscape of hormonal therapy for advanced prostate cancer, with earlier implementation of androgen pathway
  • How does real life treatment of prostate cancer differ from patients defined in clinical trials?
  • How does optimal CVD management influence overall outcome?
  • Collaboration across specialties?
  • How to monitor/minimize CV toxicity

 

image

 

 

This program has received financial support from Ferring in the form of an educational grant

The Canadian Urological Association (CUA) does not provide professional medical advice, diagnosis or treatment and cannot respond to requests for direct feedback, specific patient information or physician referrals. You should first always seek the advice of your urologist, physician and other qualified health provider with any questions regarding your medical condition. The contents of the CUA Website such as text, graphics, images, and other content are for informational purposes only. The content/information is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Never disregard professional medical advice or delay in seeking it because of something you have read on the CUA website.

For comments or information, email Corporate.office@cua.org

Privacy Policy